Eberhardt Kuhn, PhD, Joins Cannabis Science and Technology® Editorial Advisory Board
Cannabis Science and Technology® is pleased to announce the addition of Eberhardt Kuhn, PhD, to its editorial advisory board (EAB).
Eberhardt Kuhn, PhD, is the marketing manager for food, cannabis, and hemp at Shimadzu Scientific Instruments and an acclaimed chromatographer with more than 30 years of experience in this field. He has also worked for companies like Restek, Agilent, and Bio-Rad.
Dr. Kuhn has had the opportunity to speak at various conferences and events in over 30 countries. He holds expertise in chromatographic separations, column chemistry, and scientific instrumental analysis of food, including determination and identification of contaminants (pesticides, heavy metals, and food contact materials such as per- and polyfluoroalkyl substances [PFAS]), food quality, food adulteration and confirmation of food authenticity, and general analytical method development. Dr. Kuhn is currently interested in cannabis and hemp analytics—potency, terpenes, contamination—and educating the public on the numerous benefits of cannabis and hemp.
For a complete list of the Cannabis Science and Technology® Editorial Advisory Board members please visist: www.cannabissciencetech.com/cannabis-science-and-technology-editorial-advisory-board.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
German Medical Cannabis Market Has Yet to Reach Its Full Potential
December 25th 2024Germany’s Cannabis Act (CanG) is beginning to transform the country's medical cannabis market, with potential opportunities to expand telemedicine, improve physician training, and enhancing accessibility in this rapidly growing industry.
